Germ line transmission of the Cdk4R24C mutation facilitates tumorigenesis and escape from cellular senescence

Molecular and Cellular Biology

Volumn 22, Issue 2, 2002, Pages 644-656

  Rane, S G ^a   Cosenza, S C ^a   Mettus, R V ^a   Reddy, E P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ARGININE; CARCINOGEN; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; CYSTEINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P107; PROTEIN P130; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL AGING; CELL DIVISION; CELL GROWTH; CELL IMMORTALIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GENE LOCUS; GENE MUTATION; GERM LINE; HYPOPHYSIS TUMOR; MELANOMA; MOUSE; NONHUMAN; ONCOGENE; PANCREAS CANCER; PAPILLOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKIN CANCER;

ANIMALS; CELL AGING; CELL CYCLE; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; COCARCINOGENESIS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; GENES, RAS; GERM-LINE MUTATION; HUMANS; MICE; MICE, MUTANT STRAINS; NEOPLASMS, EXPERIMENTAL; ONCOGENES; PHENOTYPE; PROTO-ONCOGENE PROTEINS; SKIN NEOPLASMS;

ANIMALIA;

EID: 0036134935     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.2.644-656.2002     Document Type: Article

References (53)

1. Cancer, aging and cellular senescence
2. Kip1 CDK inhibitors are essential activators of cyclin-D dependent kinases in murine fibroblasts
3. The INK4a/ARF tumor suppressor: One gene - two products - two pathways
4. Essential role for oncogenic Ras in tumour maintenance
5. Requirement for a functional Rb-1 gene in murine development
6. Shared role of the pRB-related p130 and p107 proteins in limb development
7. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions
8. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
9. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
10. Relationship between Ras pathways and cell cycle control
11. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
12. Quantitation of early clonal expansion of two mutant 61st codon c-Ha-ras alleles in DMBA/TPA treated mouse skin by nested PCR/RFLP
13. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis
14. Role of the retinoblastoma family, pRb, p107 and p130 in the negative control of cell growth
15. Splicing into senescence: The curious case of p16 and p19ARF
16. The serial cultivation of human diploid cell strains
17. The retinoblastoma protein: A master regulator of cell cycle, differentiation and apoptosis
18. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance
19. Effects of an Rb mutation in the mouse
20. A cell cycle regulator potentially involved in genesis of many tumor types
21. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
22. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
23. New functional activities for the p21 family of CDK inhibitors
24. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
25. Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene
26. Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene
27. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
28. Targeted disruption of p107: Functional overlap between p107 and Rb
29. p53: Only ARF the story
30. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
31. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
32. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
33. Signaling to p53: Breaking the MDM2-p53 circuit
34. Ras inactivation of the retino-blastoma pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells
35. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
36. 1 phase in rodent fibroblasts
37. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia
38. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo
39. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization
40. Role of the INK4a locus in tumor suppression and cell mortality
41. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
42. Oncogenic Ras-mediated cell growth arrest and apoptosis are associated with increased ubiquitin-dependent cyclin D1 degradation
43. The Pezcoller lecture: Cancer cell cycles revisited
44. CDK inhibitors: Positive and negative regulators of G1-phase progression
45. Cellular senescence: Mitotic clock or culture shock?
46. Molecular mechanisms for the senescent cell cycle arrest
47. Quantitative studies of the growth of the mouse embryo cells in culture and their development into established cell lines
48. Developmental defects and tumor predisposition in Rb mutant mice
49. p53: Death star
50. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
51. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
52. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
53. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma